Literature DB >> 9366402

Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism.

G J Christianson1, W Brooks, S Vekasi, E A Manolfi, J Niles, S L Roopenian, J B Roths, R Rothlein, D C Roopenian.   

Abstract

The goal of this study was to determine whether class I proteins play an important role in the regulation of Ig and to elucidate the mechanism(s) involved. We analyzed the phenotype imposed by a null allele of beta 2-microglobulin (beta 2m). Serum Ig levels of several mouse strains showed a beta 2m dependence that was most evident in mice genetically predisposed to develop chronic systemic lupus erythematosus, was preferential to IgG isotypes, and was greatly exaggerated in aging mice that normally develop hypergammaglobulinemia. Beta 2m-deficient mice, regardless of genetic background, also displayed a substantial reduction of specific Ab in response to a prototypic T cell-dependent Ag and a prototypic T cell-independent 2 Ag. This reduction could be accounted for by a selective diminution of Abs of the IgG class. Therefore, class I proteins play a considerable role in the regulation of Ig. The beta 2m dependence could not be explained by class I-dependent immunoregulatory cells (CD8+ cells, NK1.1+ T cells, or conventional NK+ cells) or by the transfer of maternal IgG into the prenatal/neonatal mouse made possible by the beta 2m-dependent Fc receptor (FcRn). However, a beta 2m-dependent increase in the half-lives of IgG, presumably conferred by lifelong FcRn expression, was observed in all mice regardless of genetic background and age. We conclude that FcRn-mediated protection of IgG from catabolism is a generic mechanism that best explains the lifelong beta 2m dependence of Ig in both normal and pathologic situations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366402

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  Transcytosis and catabolism of antibody.

Authors:  Victor Ghetie; E Sally Ward
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.

Authors:  Imre Kacskovics; Judit Cervenak; Anna Erdei; Richard A Goldsby; John E Butler
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

3.  Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.

Authors:  Najib El Haddad; Dean Heathcote; Robert Moore; Sunmi Yang; Jamil Azzi; Bechara Mfarrej; Mark Atkinson; Mohamed H Sayegh; Jeng-Shin Lee; Philip G Ashton-Rickardt; Reza Abdi
Journal:  Blood       Date:  2010-11-12       Impact factor: 22.113

4.  IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity.

Authors:  Masaru Yoshida; Atsuhiro Masuda; Timothy T Kuo; Kanna Kobayashi; Steven M Claypool; Tetsuya Takagawa; Hiromu Kutsumi; Takeshi Azuma; Wayne I Lencer; Richard S Blumberg
Journal:  Springer Semin Immunopathol       Date:  2006-10-19

5.  Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice.

Authors:  P Bilinski; D Roopenian; A Gossler
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

6.  Antigenic Hsp70-peptide upregulate altered cell surface MHC class I expression in TAMs and increases anti-tumor function in Dalton's lymphoma bearing mice.

Authors:  Pramod Kumar Gautam; Arbind Acharya
Journal:  Tumour Biol       Date:  2014-11-28

7.  The heavy chain of neonatal Fc receptor for IgG is sequestered in endoplasmic reticulum by forming oligomers in the absence of beta2-microglobulin association.

Authors:  Xiaoping Zhu; Junmin Peng; Raktima Raychowdhury; Atsushi Nakajima; Wayne I Lencer; Richard S Blumberg
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 8.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

9.  Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Authors:  Linda S Wyatt; Patricia L Earl; Leigh Anne Eller; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

Review 10.  Role of Fc Receptors as a therapeutic target.

Authors:  Atsuhiro Masuda; Masaru Yoshida; Hideyuki Shiomi; Yoshinori Morita; Hiromu Kutsumi; Hideto Inokuchi; Shigeto Mizuno; Akira Nakamura; Toshiyuki Takai; Richard S Blumberg; Takeshi Azuma
Journal:  Inflamm Allergy Drug Targets       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.